BRIEF-Lexagene Intends To Pursue Full Panel Pathogen Testing Through The FDA
BRIEF-Lexagene Intends To Pursue Full Panel Pathogen Testing Through The FDA
Brief-Lexagene打算通過FDA進行全面的病原體測試
Nov 24 (Reuters) - Lexagene Holdings Inc LXG.V :
路透11月24日電-Lexagene Holdings Inc LXG.V:
* LEXAGENE INTENDS TO PURSUE FULL PANEL PATHOGEN TESTING THROUGH THE FDA
*LEXAGENE打算通過FDA進行全面小組病原體測試
Source text for Eikon: ID:nGNX1YmwW9 Further company coverage: LXG.V
Eikon的源文本:ID:nGNX1YmwW9進一步的公司報道:LXG.V
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com;)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。